Search Medical Condition
Please enter condition
Please choose location

Peoria, Arizona Clinical Trials

A listing of Peoria, Arizona clinical trials actively recruiting patient volunteers.

RESULTS

Found (155) clinical trials

Study With Oral Ferric Maltol for the Treatment of Iron Deficiency Anemia in Subjects With Chronic Kidney Disease

To evaluate the efficacy of oral ferric maltol compared with placebo in the treatment of IDA in subjects with CKD

Phase

0.0 miles

Learn More »

Safety Follow-up Study in Subjects With Silicone Gel-filled Breast Implants as Compared Both to Saline-filled Breast Implants and to National Norms

Ten year safety study examining rates of rare adverse events, child bearing issues, effects of mammography, MRI compliance and results, and long-term benefit of silicone-filled breast implants.

Phase N/A

1.85 miles

Learn More »

A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females

This study will evaluate the safety and effectiveness of the investigational drug DDP733 in treating female patients with IBS-c. A placebo control will be utilized.

Phase

1.85 miles

Learn More »

A phase3, multi-center, placebo-controlled, randomized, double-blind, 12-week study with a 40-week, active-controlled, double-blind extension to evaluate the efficacy and safety of an investigational medication in adult patients with fasting triglyceride levels greater than or equal to 500mg/dL and less than 2,000 mg/dL and Normal or Impaired renal function. Eligibility Criteria: ...

Phase

1.85 miles

Learn More »

The primary objectives of this study are to evaluate the efficacy of ascending doses of COR-003 in subjects with elevated levels of cortisol due to endogenous Cushing's Syndrome by assessment of reduction in Urinary Free Cortisol (UFC) concentrations and to identify the range of safe and effective doses of COR-003 ...

Phase

1.85 miles

Learn More »

This study is approximately 15 months long and will assess the effectiveness and safety of an investigational medication compared to a placebo which has no therapeutic effects. This research study involves one of the following 3 treatments when added to some regularly prescribed medications: 150mg once a day of Investigational ...

Phase

1.85 miles

Learn More »

A stage 1, prospective, randomized, placebo-controlled, double-blind study to evaluate the safety and efficacy of Alpha 1-proteinase Inhibitor (A1P1) augmentation therapy in subjects with A1P1 Deficiency and chronic obstructive pulmonary disease (COPD). This study is an approximately 2 year study that will evaluate the safety and effectiveness of the FDA ...

Phase N/A

1.85 miles

Learn More »

This study is an approximately 2 year study that will evaluate the safety and effectiveness of the FDA approved drugs Aralast NP and Glassia in COPD patients with Alpha 1 Antitrypsin Deficiency compared to placebo.

Phase N/A

1.85 miles

Learn More »

PHASE 2A, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTIPLE-DOSE, 2-PART STUDY TO ASSESS THE SAFETY, TOLERABILITY AND PHARMACOKINETIC RESPONSE AND EXPLORE THE PHARMACODYNAMIC RESPONSE FOLLOWING 4 WEEKS OF ONCE WEEKLY SUBCUTANEOUS INJECTIONS OF PB1046 IN ADULT SUBJECTS WITH STABLE HEART FAILUREWITH REDUCED EJECTION FRACTION (HFREF) (PART 1) AND IN SUBJECTS WITH CARDIAC DYSFUNCTION ...

Phase

1.85 miles

Learn More »

This study is a 2 year study that will evaluate the effectiveness and safety of the investigational medication, Sotagliflozin. Dosing for this study involves 2 tablets of Sotagliflozin by mouth daily or 2 tablets of placebo, which has no therapeutic effect.

Phase

1.85 miles

Learn More »